Germany is the bigger Breast Cancer Diagnostic market: $150 Mn against $107 Mn in 2023, about 1.4 times as large.
Germany grows faster: 6% a year, against 5.8%.
Clinical research: 215 active trials in the UK, 212 in Germany.
| Measure |  UK |  Germany |
|---|---|---|
| Market size, 2023 | $107 Mn | $150 Mn |
| Market size, 2033 projected | $187 Mn | $269 Mn |
| Growth a year (CAGR) | 5.8% | 6% |
| Money added, 2023–2033 | $81 Mn | $119 Mn |
| Share of the world market | 2.6% | 3.7% |
| Size rank of 24 countries | #7 | #5 |
| Market per person, 2023 | $1.53 | $1.80 |
| Active clinical trials | 215 | 212 |
| Full report | UK report | Germany report |
Year by year, 2023 to 2033
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
UK Germany · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Breast Cancer Diagnostic, UK or Germany?
Germany is the bigger Breast Cancer Diagnostic market: $150 Mn against $107 Mn in 2023, about 1.4 times as large.
Which grows faster in Breast Cancer Diagnostic, UK or Germany?
Germany grows faster: 6% a year, against 5.8%.
More Breast Cancer Diagnostic comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.